DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

Sangamo Therapeutics Q4 EPS $(0.04) Beats $(0.33) Estimate, Sales $54.9M Up From $26.8M YoY

Sangamo Therapeutics (NASDAQ:SGMO) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.33) by 87.88 percent. This is a 77.78 percent increase over losses of $(0.18) per share

Benzinga · 02/28/2020 12:03

Sangamo Therapeutics (NASDAQ:SGMO) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.33) by 87.88 percent. This is a 77.78 percent increase over losses of $(0.18) per share from the same period last year. The company reported $54.9 million in sales this quarter. This is a 104.85 percent increase over sales of $26.8 million the same period last year.